The DOI matches its Crossref record.
All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization
Abstract
The E5 oncoprotein of human papillomavirus type 16 downregulates surface MHC Class I and interacts with the heavy chain of the MHC complex via the first hydrophobic domain, believed to form the first helical transmembrane region (TM1) of E5. TM1 contains 4 equally spaced di‐leucine (LL1‐LL4) motifs. Di‐leucine motifs have been implicated in protein–protein interactions and as localization signals. To see if any of the 4 di‐leucine motifs of TM1 are involved in MHC downregulation by E5, we mutated each LL pair into valine pairs (VV1‐VV4), as mutation of leucine to valine is not expected to cause major structural alterations in E5. We found that all 4 mutations disrupted the intracellular location of E5 and abrogated its MHC I downregulating activity; however VV2 and VV4 mutants were still able to interact physically with the MHC I heavy chain (HC) in vitro , while VV1 and VV3 mutants had lost this activity. We conclude that LL1 and LL3 are necessary for the interaction with HC, but LL2 and LL4 are not. However all 4 LL motifs are responsible for the proper localization of E5 in the Golgi/ER, and the displacement of E5 from this location contributes to the abrogation of MHC I downregulation. LL1 and LL3 motifs are expected to be on one face of the TM1 helix and LL2 and LL4 on the opposite face. We propose that E5 interacts with HC via LL1 and LL3 and that all 4 di‐leucine motifs act as a targeting signal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanistically, this has been linked to interaction of HPV-16 E5 with MHC class I through E5’s first helical transmembrane domain (TM1), and to E5’s location in Golgi/ER, possibly interfering with the trafficking of MHC molecules to the cell surface, as dislocation of E5 from Golgi/ER leads to the abrogation of MHC I downregulation [345,346].”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [345]
In the citing paper
“Mechanistically, this has been linked to interaction of HPV-16 E5 with MHC class I through E5’s first helical transmembrane domain (TM1), and to E5’s location in Golgi/ER, possibly interfering with the trafficking of MHC molecules to the cell surface, as dislocation of E5 from Golgi/ER leads to the abrogation of MHC I downregulation [345,346].”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [345]
In the citing paper
“Mechanistically, this has been linked to interaction of HPV-16 E5 with MHC class I through E5’s first helical transmembrane domain (TM1), and to E5’s location in Golgi/ER, possibly interfering with the trafficking of MHC molecules to the cell surface, as dislocation of E5 from Golgi/ER leads to the abrogation of MHC I downregulation [345,346].”
From The Not-So-Good, the Bad and the Ugly: HPV E5, E6 and E7 Oncoproteins in the Orchestration of Carcinogenesis (2021) · cites this paper as [345]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 29
- 10.1016/S0168-1702(02)00123-5 · DOI
- 10.1016/j.virol.2008.11.046 · DOI · Paper page
- 10.1002/ijc.20558 · DOI · Paper page
- 10.1002/ijc.22089 · DOI · Paper page
- 10.1128/JVI.77.5.2819-2831.2003 · DOI
- 10.1128/JVI.77.5.2832-2842.2003 · DOI
- Suprynowicz FA, 2006, Papillomavirus Research: From Natural History to Vaccines and Beyond, 97
- Leechanachai P, 1992, The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor‐mediated signal transduction to the nucleus, Oncogene, 7, 19
- 10.1158/0008-5472.CAN-05-0083 · DOI · Paper page
- 10.1016/j.virusres.2006.02.005 · DOI
- 10.1016/S0042-6822(03)00509-9 · DOI
- 10.1186/1475-2867-6-19 · DOI
- 10.1006/jmbi.2000.4315 · DOI · Paper page
- 10.2144/97233st02 · DOI
- 10.1038/sj.onc.1209245 · DOI
- 10.4049/jimmunol.177.9.6172 · DOI
- 10.1529/biophysj.103.038422 · DOI
- 10.1186/1743-422X-5-30 · DOI
- 10.1099/vir.0.016295-0 · DOI
- 10.1099/0022-1317-81-6-1517 · DOI
- Chan SY, 1992, Molecular variants of human papillomavirus type 16 from 4 continents suggest ancient pandemic spread of the virus and its coevolution with humankind, J Virol, 66, 2057, 10.1128/jvi.66.4.2057-2066.1992 · DOI
- 10.1128/JVI.79.11.7014-7023.2005 · DOI
- 10.1099/0022-1317-80-3-595 · DOI
- 10.1007/s00705-004-0325-8 · DOI
- 10.1186/1743-422X-4-116 · DOI · Paper page
- 10.1093/emboj/18.4.1081 · DOI
- 10.1146/annurev.biochem.72.121801.161800 · DOI · Paper page
- 10.1128/JVI.01240-08 · DOI
- 10.1006/jmbi.1999.3488 · DOI
Cited by
Basukala, O., & Banks, L. (2021) · Viruses · doi:10.3390/v13101892 · Cited by 137
Metadata
- Authors
- Cortese, M. S., Ashrafi, G. H., & Campo, M. S.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2010-01-28
- Volume
- 126
- Issue
- 7
- Pages
- 1675-1682
- ISSN
- 0020-7136
- 1097-0215
- Cited by
- 53
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review